Ben Tre Pharmaceutical JSC (DBT) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Ben Tre Pharmaceutical JSC

DHG Pharmaceutical JSC

F.I.T. Investment JSC

Domesco Medical Import-Export JSC

Binh Dinh Pharmaceutical & Medical Equipment JSC

OPC Pharmaceutical JSC

Mediplantex National Pharmaceutical JSC

Imexpharm Corp.

Ha Tay Pharmaceutical JSC

Cuu Long Pharmaceutical JSC

Mekophar Chemical Pharmaceutical JSC

Why is Ben Tre Pharmaceutical JSC ?

Poor Management Efficiency with a low ROCE of 6.47%

The company has been able to generate a Return on Capital Employed (avg) of 6.47% signifying low profitability per unit of total capital (equity and debt)

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of 0.24% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Capital Employed (avg) of 6.47% signifying low profitability per unit of total capital (equity and debt)

Flat results in Mar 25

PRE-TAX PROFIT(Q) At VND 3,262.88 MM has Fallen at -61.68%
NET PROFIT(Q) At VND 2,655.74 MM has Fallen at -64.09%
ROCE(HY) Lowest at 3.83%

With ROE of 6.04%, it has a fair valuation with a 0.93 Price to Book Value

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 0.37%, its profits have risen by 8.9%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Ben Tre Pharmaceutical JSC should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Ben Tre Pharmaceutical JSC for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Ben Tre Pharmaceutical JSC

0.37%

-0.11

24.45%

Vietnam VN Ho Chi Minh Index

29.95%

1.61

21.07%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.24%

EBIT Growth (5y)

11.61%

EBIT to Interest (avg)

1.17

Debt to EBITDA (avg)

6.97

Net Debt to Equity (avg)

1.86

Sales to Capital Employed (avg)

1.13

Tax Ratio

40.07%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

6.47%

ROE (avg)

9.10%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.93

EV to EBIT

12.79

EV to EBITDA

9.89

EV to Capital Employed

0.98

EV to Sales

0.89

PEG Ratio

Dividend Yield

0.64%

ROCE (Latest)

7.63%

ROE (Latest)

6.04%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Sideways

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

OPERATING CASH FLOW(Y)

Highest at VND -4,340.56 MM

RAW MATERIAL COST(Y)

Fallen by -17.65% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 4.25%

OPERATING PROFIT MARGIN(Q)

Highest at 10.78 %

-18What is not working for the Company

PRE-TAX PROFIT(Q)

At VND 3,262.88 MM has Fallen at -61.68%

NET PROFIT(Q)

At VND 2,655.74 MM has Fallen at -64.09%

ROCE(HY)

Lowest at 3.83%

NET SALES(Q)

Lowest at VND 161,230.72 MM

Here's what is working for Ben Tre Pharmaceutical JSC

Operating Cash Flow

Highest at VND -4,340.56 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (VND MM)

Operating Profit Margin

Highest at 10.78 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Debtors Turnover Ratio

Highest at 4.25%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -17.65% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Ben Tre Pharmaceutical JSC

Pre-Tax Profit

At VND 3,262.88 MM has Fallen at -61.68%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (VND MM)

Net Profit

At VND 2,655.74 MM has Fallen at -64.09%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (VND MM)

Net Sales

Lowest at VND 161,230.72 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (VND MM)

Net Sales

Fallen at -13.02%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (VND MM)